Since its debut in 2002, the annual Bio-IT World Conference & Expo has established itself as a premier event showcasing the myriad of IT and informatics applications and enabling technologies that drive biomedical research, drug discovery & development, and clinical and healthcare initiatives.
The ISPOR US meeting features a comprehensive scientific program which will address vital questions on topics including rapid advances in information technology, medical technology, and targeted pharmaceuticals combined with transformations in regulatory decision making, health insurance, payment and delivery systems.
ASCO provides exemplary education and resources to support oncology practices and promote the delivery of high-quality, high-value cancer care.
PAGE represents a community with a shared interest in data analysis using the population approach.
ACoP is the annual scientific meeting of the International Society of Pharmacometrics (ISoP).
IDWeek is the joint annual meeting of the Infectious Diseases Society of America (IDSA), Society for Healthcare Epidemiology of America (SHEA), the HIV Medical Association (HIVMA), the Pediatric Infectious Diseases Society (PIDS), and the Society of Infectious Diseases Pharmacists (SIDP). IDWeek is a forum for health professionals of varied...
The American Association of Pharmaceutical Scientists (AAPS) is a professional, scientific organization of approximately 7,000 individual members and over 10,000 actively participating stakeholders employed in academia, industry, government, and other pharmaceutical science related research institutes worldwide.
ISPOR Europe 2019 convenes an international, interdisciplinary audience of 5000+ healthcare stakeholders that include policy makers, payers, thought leaders, researchers, decision makers, and patient representatives.
The 3rd edition of the World Conference on Pharmacometrics (WCoP) to be held at the southern tip of the continent of Africa on 6-9 April 2020 in Cape Town, South Africa.
ASCPT is a meeting for clinical pharmacologists, translational scientists, and other scientists in the early phase drug discovery, development, regulatory, and utilization space to collaborate and help improve patient care.
SOT is dedicated to Creating a Safer and Healthier World by Advancing the Science and Increasing the Impact of Toxicology.
The Neurodegenerative Drug Development Summit will unite industry stakeholders to learn how to overcome their translational challenges, share their progress and network for future collaborations to accelerate the development of successful neurodegenerative therapeutics.
Discover. Invest. Cure. The investor conference that drives the future of drug development. More than $400 billion in capital represented.